Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico…
Lay off/Spin-off/Appointments
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Lay off/Spin-off/Appointments
X-Vax Technology Appoints Isaac Blech as Vice Chairman to its Board…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Lay off/Spin-off/Appointments
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Clinical
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement…
Clinical
Medicine Supply Notification: Ketotifen 1mg/5ml elixir (Zaditen) – FirstWord Pharma
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Sanofi eyes acquisitions in US, including Principia Biopharma: report – FirstWord…
Clinical
Lilly’s mirikizumab superior to Novartis’ Cosentyx in psoriasis study – FirstWord…
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Lay off/Spin-off/Appointments
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Home
Commercial
Lay off/Spin-off/Appointments
Lay off/Spin-off/Appointments
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lay off/Spin-off/Appointments
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor) Research – FirstWord Pharma
Firstwordpharma News
-
July 18, 2020
Lay off/Spin-off/Appointments
X-Vax Technology Appoints Isaac Blech as Vice Chairman to its Board of Directors
Lay off/Spin-off/Appointments
Idorsia establishes US commercial operations and leadership team Swiss Stock Exchange:IDIA
Lay off/Spin-off/Appointments
Emerging Markets Report: A Changing of the Guard Other OTC:OWPC
Lay off/Spin-off/Appointments
Glympse Bio Announces $46.7 Million Series B Financing
Lay off/Spin-off/Appointments
ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical...
Biospace News
-
July 15, 2020
0
Lay off/Spin-off/Appointments
Vivera Pharmaceuticals Welcomes Tony Sanchez, Jr. to its Advisory Board
Biospace News
-
July 15, 2020
0
Lay off/Spin-off/Appointments
AnaptysBio Expands Executive Leadership TeamAppoints Dennis Mulroy as Chief Financial Officer...
Biospace News
-
July 15, 2020
0
Lay off/Spin-off/Appointments
Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology...
Biospace News
-
July 15, 2020
0
Lay off/Spin-off/Appointments
FDA Approves Expanded BOTOX (onabotulinumtoxinA) Label for the Treatment of Pediatric...
Firstwordpharma News
-
July 12, 2020
0
1
2
3
...
51
Page 1 of 51
- Advertisement -
MOST POPULAR
Targovax and IOVaxis Therapeutics Enters Option Agreement for TG Mutant RAS...
January 8, 2020
Clover Health Launches Clover Therapeutics, a New Research Subsidiary to Develop...
July 10, 2019
Roche wins approval for cancer drug Kadcyla in fast-growing China market...
January 22, 2020
ASH19: Sanofi’s C1s inhibitor sutimlimab increases haemoglobin levels in patients with...
December 10, 2019
Load more
HOT NEWS
Others
MorphoSys Continues to Build Commercial Presence by Opening new U.S. Headoffice
Deals
BenevolentAI announces scientific collaboration with UC San Diego to investigate Cerebral...
Commercial
PRA Health Sciences Melancarkan Program Pemantauan COVID-19 Nasdaq:PRAH
Others
Neon Therapeutics Announces New Strategic Focus on Novel T Cell Programs
